| Disease | Myelodysplasic syndromes (MDS) in 60 % of cases, often evolving towards acute non lymphoblastic leukaemia (ANLL); ANLL in 30%, frequently with preceeding MDS; these MDS or ANLL are therapy-related (secondary to toxic exposure) in half cases; myeloproliferative diseases (MPD) represent the remaining 10% of cases |
| Phenotype / cell stem origin | MDS cases: often RAEB±T or RA; ANLL: M4 or M1; MPD cases: myelofibrosis |
| Epidemiology | represent 3-7 % of secondary leukaemias, 0.5% and 2% of de novo ANLL and MDS respectively; adults mostly (median 60 yrs; only a very few children cases); male predominance (3M/2F), but secondary leukaemias cases are more frequently female cases (presence of uncovered environmental genotoxic factors in male cases ?). |
| Prognosis | poor prognosis; median survival was reviewed in 1992 and was found to be of 11 mths; male sex, a low haemoglobin level may be adverse prognostic features; prognosis is better, obviously in case of a MPD. |
| An identical translocation between chromosome 1 and 7 in three patients with myelofibrosis and myeloid metaplasia. |
| Geraedts JP, den Ottolander GJ, Ploem JE, Muntinghe OG |
| British journal of haematology. 1980 ; 44 (4) : 569-575. |
| PMID 7378317 |
| |
| Translocation t(1;7) revisited. Report of three further cases and review. |
| Willem P, Pinto M, Bernstein R |
| Cancer genetics and cytogenetics. 1988 ; 36 (1) : 45-54. |
| PMID 3060251 |
| |
| The unbalanced 1;7 translocation in de novo myelodysplastic syndrome and its clinical implication. |
| Horiike S, Taniwaki M, Misawa S, Nishigaki H, Okuda T, Yokota S, Kashima K, Inazawa J, Abe T |
| Cancer. 1990 ; 65 (6) : 1350-1354. |
| PMID 2306683 |
| |
| Cytogenetics of secondary myelodysplasia (sMDS) and acute nonlymphocytic leukemia (sANLL). |
| Johansson B, Mertens F, Heim S, Kristoffersson U, Mitelman F |
| European journal of haematology. 1991 ; 47 (1) : 17-27. |
| PMID 1868912 |
| |
| Survival of patients with t(1;7)(p11;p11). Report of two cases and review of the literature. |
| Pedersen B |
| Cancer genetics and cytogenetics. 1992 ; 60 (1) : 53-59. |
| PMID 1591707 |
| |